GSK PLC
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc(the 'Company')
Transaction notification
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Sir Jonathan Symonds
| |||
b)
|
Position/status
|
Non-Executive Chair
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of31 ¼pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Purchase of 1,900 Ordinary Shares
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£15.2600
|
1,900
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Urs Rohner
| |||
b)
|
Position/status
|
Independent Non-Executive Director
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of31 ¼pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Purchase of 453 Ordinary Shares
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£15.2880
|
453
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Charles Bancroft
| |||
b)
|
Position/status
|
Senior Independent Non-Executive Director
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
| |||
b)
|
Nature of the transaction
|
Purchase of 1,691 ADSs
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
$38.0255
|
1,691
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Dr Hal Barron
| |||
b)
|
Position/status
|
Non-Executive Director
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
| |||
b)
|
Nature of the transaction
|
Purchase of 219 ADSs
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
$38.0255
|
219
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Dr Anne Beal
| |||
b)
|
Position/status
|
Independent Non-Executive Director
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
| |||
b)
|
Nature of the transaction
|
Purchase of 220 ADSs
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
$38.0255
|
220
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Dr Harry Dietz
| |||
b)
|
Position/status
|
Independent Non-Executive Director
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
| |||
b)
|
Nature of the transaction
|
Purchase of 220 ADSs
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
$38.0255
|
220
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Dr Jesse Goodman
| |||
b)
|
Position/status
|
Independent Non-Executive Director
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
| |||
b)
|
Nature of the transaction
|
Purchase of 220 ADSs
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
$38.0255
|
220
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Elizabeth McKee Anderson
| |||
b)
|
Position/status
|
Independent Non-Executive Director
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
| |||
b)
|
Nature of the transaction
|
Purchase of 219 ADSs
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
$38.0255
|
219
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Dr Vishal Sikka
| |||
b)
|
Position/status
|
Independent Non-Executive Director
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
| |||
b)
|
Nature of the transaction
|
Purchase of 790 ADSs
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
$38.0255
|
790
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume Price
| |||||
e)
|
Date of the transaction
|
2023-09-20
| |||
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GSK plc published this content on 21 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 September 2023 02:13:11 UTC.
